Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

Polaryx Therapeutics, Inc.

polaryx.com
Filed: May 27, 2026CIK: 0002075320Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Polaryx Therapeutics completed a $10 million private placement with approximately 35 investors, including existing shareholder MStone Partners Healthcare Limited, raising capital to support operations and growth initiatives.

Key Takeaways

Company raised $10 million through private placement of 2,502,696 common shares at approximately $3.99 per share

MStone Partners Healthcare Limited, the largest stockholder, invested $360,000 for 88,453 shares, demonstrating continued confidence from major shareholders

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMay 27, 2026
Item1.01
CategoryMaterial Agreement
CIK0002075320
Accession #0002075320
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
stock offering

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings